⬛ Ryman Healthcare ⬛ Running Ryman for Cash
Ryman Healthcare (RYM) is focusing on maximizing cash generation, reducing risks but also limiting upside. The company's new FY26 and FY27 guided...
119 Views
Ryman Healthcare - Running Ryman for Cash
We value RYM using our annuity earnings including resale gains and a dividend discount model (DDM). We reinstate our rating at NEUTRAL.
209 Views
Ryman Healthcare - NZ$1bn Equity Raise and Market Update
Ryman Healthcare (RYM) is raising NZ$1bn in equity to create a sustainable capital structure, reducing September 2024 pro-forma gearing from 37.3%...
498 Views
Ryman Healthcare - 1H25 Result — Structural Gain, Cyclical Pain
Ryman Healthcare (RYM) used to dress up weak results to make them look good. In the last two results the opposite has been true.
413 Views
Ryman Healthcare - 1H25 Preview — Let Go of Yesterday
After it lifted the veil on a decade of opaque accounting practices and half truths at its FY24 result, we expect its 1H25 result to be a...
273 Views